MYRIAD GENETICS INC

Nasdaq:MYGN

In Vitro & In Vivo Diagnostic Substances·SALT LAKE CITY, UT

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States.

CEO

Raha Samraat S.

CFO

Wheeler Benjamin Richard

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/24/26	→
10-Q	Q3 2025	9/30/25	11/4/25	→
10-Q	Q2 2025	6/30/25	8/6/25	→
10-Q	Q1 2025	3/31/25	5/7/25	→
10-K	FY 2024	12/31/24	2/28/25	→
10-Q	Q3 2024	9/30/24	11/8/24	→
↓

Earnings Releases (8-K)

35 shown

Filed	Period
2/23/26	Q1 FY2026	→
1/12/26	Q4 FY2026	→
11/4/25	Q4 FY2025	→
11/3/25	Q4 FY2025	→
8/5/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
↓

News (8-K)

45 shown

Filed	Type	Description
10/7/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/3/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
8/18/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
7/31/25	Agreement	Entry into a Material Definitive Agreement	→
6/5/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/10/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

22 shown

Filed	Form	Description
3/4/26	424B3	424B3	→
2/24/26	S-3	S-3	→
6/5/25	S-8	S-8	→
5/1/25	S-8	S-8	→
4/9/25	ARS	ARS	→
4/17/24	ARS	ARS	→
↓

Filing History(1001 filings)

TypeDateAccessionPeriodSize

Mar 9, 2026

0001738340-26-000002FORM 4

Mar 9, 2026

4.9 KB

EFFECT

Mar 4, 2026

9999999995-26-000727

—

1.7 KB

424B3

Mar 4, 2026

0000899923-26-000029424B3

—

177.1 KB

Mar 2, 2026

0001472827-26-000002FORM 4

Mar 1, 2026

4.7 KB

Feb 27, 2026

0001471518-26-000002FORM 4

Feb 25, 2026

9.3 KB

S-3

Feb 24, 2026

0000899923-26-000020S-3

—

1.2 MB

10-K

Feb 24, 2026

0000899923-26-00001810-K

Dec 31, 2025

9.2 MB

8-K

Feb 23, 2026

0000899923-26-0000128-K

Feb 23, 2026

688.3 KB

SCHEDULE 13G/A

Feb 11, 2026

0001104659-26-013531

—

19.0 KB

SCHEDULE 13G

Feb 9, 2026

0000093751-26-000072

—

7.7 KB

Feb 3, 2026

0002082246-26-000002FORM 4

Feb 2, 2026

4.9 KB

Feb 3, 2026

0001517026-26-000002FORM 4

Feb 2, 2026

4.9 KB

Feb 3, 2026

0001922964-26-000004FORM 4

Feb 2, 2026

4.9 KB

Feb 3, 2026

0001843872-26-000003FORM 4

Feb 2, 2026

4.9 KB

SCHEDULE 13G

Jan 13, 2026

0000905148-26-000161

—

18.1 KB

8-K

Jan 12, 2026

0000899923-26-0000038-K

Jan 12, 2026

255.1 KB

Jan 2, 2026

0001922964-26-000002FORM 4

Jan 1, 2026

4.7 KB

Dec 29, 2025

0002082246-25-000008FORM 4

Dec 25, 2025

4.8 KB

Dec 12, 2025

0001738340-25-000009FORM 4

Dec 11, 2025

4.7 KB

SCHEDULE 13G/A

Nov 12, 2025

0001104659-25-110358

—

19.5 KB

SCHEDULE 13G/A

Nov 12, 2025

0000312069-25-000583

—

6.0 KB

Nov 4, 2025

0001843568-25-000008FORM 4

Nov 3, 2025

3.8 KB

10-Q

Nov 4, 2025

0000899923-25-00011210-Q

Sep 30, 2025

5.4 MB

8-K/A

Nov 4, 2025

0000899923-25-0001098-K/A

Nov 3, 2025

740.9 KB

8-K

Nov 3, 2025

0000899923-25-0001038-K

Nov 3, 2025

738.4 KB

25 filings shown

MYRIAD GENETICS INC

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1001 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/9/25	DEFA14A	DEFA14A	→
4/9/25	DEF 14A	DEF 14A	→
4/17/24	DEFA14A	DEFA14A	→
4/17/24	DEF 14A	DEF 14A	→
4/12/23	DEFA14A	DEFA14A	→
4/12/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
3/9/26	4	4	→
3/2/26	4	4	→
2/27/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
↓